Explore Our Comprehensive Pharmaceuticals Industry Research Reports
U
2024
Carcinoembryonic antigen (CEA) is a substance found on the surface of some cells. It is a type of glycoprotein produced by cells of the gastrointestinal tract during embryonic ...
Report Code : A11908 | Category : Life Sciences
U
2024
Desmoid tumor, also called aggressive fibromatosis, often occurs in the legs, arms, and abdomen. These tumors are noncancerous growths that occur in the human connective tissue. Since these ...
Report Code : A12315 | Category : Life Sciences
U
2024
Prostate-specific antigen (PSA) is a kind of protein exclusively produced by epithelial prostatic cells and is a significant tumor marker for prostate cancer. Prostate-specific molecule’s elevated presence in ...
Report Code : A12355 | Category : Life Sciences
U
2024
Antigens produced by tumor cells are known as tumor-specific antigens. They are actually cytosolic protein derivatives. Tumor antigens are promising cancer therapy possibilities because they are useful tumor markers for detecting tumor cells in diagnostic testing.
Report Code : A13611 | Category : Life Sciences
P
2022
By component, the Oncological Disorders was the dominant sub-segment with major market share in 2020 in the North America Gene Therapy Market. This sub-segment is likely to follow same momentum by the end of 2030.
Report Code : A26233 | Category : Life Sciences
P
2022
The Mexico Gene Therapy Market segment Application is expected to witness highest CAGR during the forecast period. The report provides insights about opportunities that would help the market to expand in future.
Report Code : A26234 | Category : Life Sciences
P
2022
By end user, the Canada Gene Therapy Market market is bifurcated into various sectors, Of those, Application was the largest segment and captured considerable market share in 2020.
Report Code : A26235 | Category : Life Sciences
P
2022
The U.S. Gene Therapy Market achieved significant revenue share in base year of analysis. The U.S. Gene Therapy Market size is expected to account for a considerable growth rate between 2021 to 2030.
Report Code : A26236 | Category : Life Sciences
P
2022
The Oncological Disorders is the most lucrative in terms of revenue growth in Europe Gene Therapy Market. The report analyses the market using Porter’s Five Forces Analysis, Top player Positioning and COVID-19 Impact Analysis.
Report Code : A26237 | Category : Life Sciences
P
2022
The Application dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.
Report Code : A26238 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.